Listen to Jay Bartlett and Scott Orleck on this podcast sharing their experiences and takeaways from buy-side due diligence projects.
New technologies, customers and competition are forcing — and enabling — biopharmaceutical companies to find novel ways to create and capture value.
Parthenon-EY’s Education practice assesses the potential impact of early college high schools using data and perspectives from Massachusetts and around the country.
How will companies use M&A to alter their DNA in 2017? Our oil and gas and technology sector leaders weigh in.
For the first time in the EY Entrepreneur Of The Year® US program’s 30-year history, the combined accomplishments of 9,200 men and women is quantified.
Blockchain technology is revolutionizing industries. Watch Barak Ravid and Nadine Mirchandani discuss the powerful effect of blockchain.
However logical it may have been a decade or so ago, pursuing a land-grab strategy no longer makes sense for multinationals seeking profit in Asia.
The Parthenon-EY team is committed to bringing unconventional yet pragmatic thinking together with our clients’ smarts to deliver actionable strategies for real impact in today’s complex business landscape.